226 related articles for article (PubMed ID: 1613320)
1. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
Ueno H; Yatco E; Benjamin LJ; Manning JM
J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
[TBL] [Abstract][Full Text] [Related]
2. Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.
Noguchi CT; Torchia DA; Schechter AN
J Clin Invest; 1983 Sep; 72(3):846-52. PubMed ID: 6886006
[TBL] [Abstract][Full Text] [Related]
3. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylating agent toward the 2,3-DPG binding site in hemoglobin S.
Ueno H; Manning JM
Am J Pediatr Hematol Oncol; 1988; 10(4):348-50. PubMed ID: 3239714
[TBL] [Abstract][Full Text] [Related]
4. Effects of methyl acetyl phosphate on hemoglobin S: a novel acetylating agent directed towards the DPG binding site.
Ueno H; Benjamin LJ; Manning JM
Prog Clin Biol Res; 1987; 240():105-10. PubMed ID: 3615481
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the gelation of extracellular and intracellular hemoglobin S by selective acetylation with methyl acetyl phosphate.
Ueno H; Benjamin LJ; Pospischil MA; Manning JM
Biochemistry; 1987 Jun; 26(11):3125-9. PubMed ID: 3607016
[TBL] [Abstract][Full Text] [Related]
6. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
Kuranstin-Mills J; Lessin LS
Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
[TBL] [Abstract][Full Text] [Related]
7. Current status of methyl acetimidate as an extracorporeal antisickling agent.
Chao TL; Berenfeld MR; Gabuzda TG
Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
Ueda Y; Bookchin RM
J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
[TBL] [Abstract][Full Text] [Related]
9. Effects of density and of dehydration of sickle cells on their adhesion to cultured endothelial cells.
Stone PC; Stuart J; Nash GB
Am J Hematol; 1996 Jul; 52(3):135-43. PubMed ID: 8756077
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
[TBL] [Abstract][Full Text] [Related]
11. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
[TBL] [Abstract][Full Text] [Related]
12. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
[TBL] [Abstract][Full Text] [Related]
13. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
14. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
Berkowitz LR; Orringer EP
Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
[TBL] [Abstract][Full Text] [Related]
15. Cell heterogeneity in sickle cell disease: quantitation of the erythrocyte density profile.
Rodgers GP; Schechter AN; Noguchi CT
J Lab Clin Med; 1985 Jul; 106(1):30-7. PubMed ID: 4009021
[TBL] [Abstract][Full Text] [Related]
16. Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia.
Lawrence C; Fabry ME; Nagel RL
J Lab Clin Med; 1985 Jun; 105(6):706-10. PubMed ID: 3998622
[TBL] [Abstract][Full Text] [Related]
17. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
[TBL] [Abstract][Full Text] [Related]
18. [Simple and rapid method for the fractionation of red blood cells in sickle cell anemia].
Leclerc L; Galacteros F; Magne P; Bohn B; Poyart C
Nouv Rev Fr Hematol (1978); 1985; 27(5):321-6. PubMed ID: 4080542
[TBL] [Abstract][Full Text] [Related]
19. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
Kaul DK; Liu XD
Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologically based drug treatment of sickle cell disease.
Steinberg MH
Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
